Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $66,328 (100.0% shares, 0.0% debt)

Holdings (17)

— Corbus Pharmaceuticals HLDGS 46.5%

Value ($000) $30,846 Shares 3,738,925 Est. Cost $4.33 Unrealized —

— Abeona Therapeutics Inc 17.7%

Value ($000) $11,740 Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Vascular Biogenics LTD 7.1%

Value ($000) $4,733 Shares 860,605 Est. Cost $4.61 Unrealized —

AVXL Anavex Life Sciences Corp 6.3%

Value ($000) $4,157 Shares 724,205 Est. Cost $3.56 Unrealized +45.0%

— Newlink Genetics Corp 3.4%

Value ($000) $2,254 Shares 93,533 Est. Cost $27.98 Unrealized —

— Ampio Pharmaceuticals Inc. 3.3%

Value ($000) $2,191 Shares 2,738,322 Est. Cost $6.03 Unrealized —

VNRX Volition RX LTD 2.8%

Value ($000) $1,855 Shares 461,538 Est. Cost $3.75 Unrealized +17.8%

— Alcobra Ltd 2.1%

Value ($000) $1,374 Shares 1,205,498 Est. Cost $6.71 Unrealized —

— Summit Therapeutics PLC 2.0%

Value ($000) $1,327 Shares 100,000 Est. Cost $13.27 Unrealized —

— Keryx Biopharmaceuticals Inc. 1.9%

Value ($000) $1,232 Shares 200,000 Est. Cost $10.21 Unrealized —

— Ritter Pharmaceuticals, Inc 1.7%

Value ($000) $1,139 Shares 802,434 Est. Cost $2.12 Unrealized —

— Neurotrope Inc 1.3%

Value ($000) $867 Shares 45,388 Est. Cost $19.10 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.9%

Value ($000) $620 Shares 124,096 Est. Cost $10.20 Unrealized -49.5%

— Caladrius Biosciences Inc 0.9%

Value ($000) $593 Shares 117,957 Est. Cost $3.99 Unrealized —

— Evoke Pharma Inc 0.8%

Value ($000) $543 Shares 175,000 Est. Cost $3.10 Unrealized —

— Advaxis Inc. 0.8%

Value ($000) $500 Shares 112,500 Est. Cost $3.96 Unrealized —

FOLD Amicus Therapeutics Inc. 0.5%

Value ($000) $357 Shares 50,000 Est. Cost $6.32 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Corbus Pharmaceuticals HLDGS	3,738,925	$30,846	46.5%	$4.33	—	COM	21833P103
—	Abeona Therapeutics Inc	2,359,767	$11,740	17.7%	$4.97	—	COM	00289Y107
—	Vascular Biogenics LTD	860,605	$4,733	7.1%	$4.61	—	COM	M96883109
AVXL	Anavex Life Sciences Corp	724,205	$4,157	6.3%	$3.56	+45.0%	COM NEW	032797300
—	Newlink Genetics Corp	93,533	$2,254	3.4%	$27.98	—	COM	651511107
—	Ampio Pharmaceuticals Inc.	2,738,322	$2,191	3.3%	$6.03	—	COM	03209T109
VNRX	Volition RX LTD	461,538	$1,855	2.8%	$3.75	+17.8%	COM	928661107
—	Alcobra Ltd	1,205,498	$1,374	2.1%	$6.71	—	SHS	M2239P109
—	Summit Therapeutics PLC	100,000	$1,327	2.0%	$13.27	—	SPONS ADS	86627R102
—	Keryx Biopharmaceuticals Inc.	200,000	$1,232	1.9%	$10.21	—	COM	492515101
—	Ritter Pharmaceuticals, Inc	802,434	$1,139	1.7%	$2.12	—	COM	767836109
—	Neurotrope Inc	45,388	$867	1.3%	$19.10	—	COM NEW	64129T207
ALDX	Aldeyra Therapeutics Inc	124,096	$620	0.9%	$10.20	-49.5%	COM	01438T106
—	Caladrius Biosciences Inc	117,957	$593	0.9%	$3.99	—	COM NEW	128058203
—	Evoke Pharma Inc	175,000	$543	0.8%	$3.10	—	COM	30049G104
—	Advaxis Inc.	112,500	$500	0.8%	$3.96	—	W EXP 07/15/201	007624117
FOLD	Amicus Therapeutics Inc.	50,000	$357	0.5%	$6.32	0.0%	COM	03152W109